Heterocyclic compound

CA3314841A1Pending Publication Date: 2026-08-05TAKEDA PHARMA CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CA3314841
Authority / Receiving Office: CA · CA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-11-28
Filing Date: 2019-11-27
Publication Date: 2026-08-05

Application Information

Patent Timeline

28 Nov 2018

Priority

27 Nov 2019

Application

CA3314841

05 Aug 2026

Publication

CA3314841A1

IPC: C07D487/04; A61K31/4375; A61K31/444; A61P35/00; C07D471/04

CPC: C07D487/04; C07D471/04; A61P35/00; A61K31/444; A61K31/5025; A61P43/00; A61K9/4858; A61K9/2018

Inventors: HIRAYAMA Takaharu; ITO Yoshiteru

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Provided is a compound that can have an effect of inhibiting MALT1 and is expected as useful as a prophylactic or therapeutic drug for cancer, etc. A compound represented by formula (I) [Image disponible dans le document PDF, Image available in the PDF document] a salt thereof, or a cocrystal, a hydrate or a solvate of the same.

Need to check novelty before this filing date? Find Prior Art